Cas:1006488-87-4 4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid manufacturer & supplier

Chemical Name:4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid

CAS.NO:1006488-87-4

Synonyms:4-Chloro-1-((4-chlorophenoxy)methyl)-1H-pyrazole-3-carboxylic acid

Molecular Formula:C₁₁H₈Cl₂N₂O₃

Molecular Weight:287.09900

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:64.35000

Exact Mass:285.99100

LogP:2.92460

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Chloro-1-((4-chlorophenoxy)methyl)-1H-pyrazole-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Chloro-1-((4-chlorophenoxy)methyl)-1H-pyrazole-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-1-((4-chlorophenoxy)methyl)-1H-pyrazole-3-carboxylic acid Use and application,4-Chloro-1-((4-chlorophenoxy)methyl)-1H-pyrazole-3-carboxylic acid technical grade,usp/ep/jp grade.

Related News: Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. 4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid manufacturer Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. 4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy. 4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid vendor Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it. 4-chloro-1-[(4-chlorophenoxy)methyl]pyrazole-3-carboxylic acid factory The U.S. laws governing cosmetics safety and labelling date back to 1938 and 1967, which tells you something,” Bruton said.
However, on Tuesday, Sens. Susan Collins (R-Maine) and Richard Blumenthal (D-Conn.) introduced the No PFAS in Cosmetics Act in the Senate, the Washington Post reported. The same bill was introduced in the U.S. House by Rep. Debbie Dingell (D-Michigan). It would direct the U.S. Food and Drug Administration to issue a proposed rule banning the intentional addition of PFAS in cosmetics within 270 days of the bill’s passage, and require a final rule to be issued 90 days later.
“Our bill would require the FDA to ban the addition of PFAS to cosmetics products,” Collins said in a statement. “Americans should be able to trust that the products they are applying to their hair or skin are safe.